TECOVIRIMAT SIGA Hard capsule Ref.[28350] Active ingredients: Tecovirimat

Source: European Medicines Agency (EU)  Revision Year: 2022  Publisher: SIGA Technologies Netherlands B.V., Prinsenhil 29, Breda 4825 AX, The Netherlands

Product name and form

Tecovirimat SIGA 200 mg hard capsules.

Pharmaceutical Form

Hard capsule (capsule).

Opaque gelatin capsules with an orange body and black cap, containing white to off-white powder. The body is printed with “SIGA” and the SIGA logo (a curved triangle with letters in it) followed by " " in white ink. The cap is printed with “ST-246” in white ink. The capsules are 21.7 millimeters long and 7.64 millimeters in diameter.

Qualitative and quantitative composition

Each hard capsule contains tecovirimat monohydrate equivalent to 200 mg tecovirimat.

Excipient(s) with known effect: Each capsule contains 31.5 mg lactose (as monohydrate) and 0.41 mg sunset yellow (E110).

For the full list of excipients, see section 6.1.

Active Ingredient Description
Tecovirimat

Tecovirimat is an antiviral drug against variola (smallpox) virus. Tecovirimat inhibits the activity of the orthopoxvirus VP37 protein, which is encoded by a highly conserved gene in all members of the orthopoxvirus genus. Tecovirimat blocks the interaction of VP37 with cellular Rab9 GTPase and TIP47, which prevents the formation of egress competent enveloped virions necessary for cell-to-cell and long-range dissemination of virus.

List of Excipients

Capsule content:

Silica, hydrophobic colloidal
Croscarmellose sodium (E468)
Hypromellose (E464)
Lactose monohydrate
Magnesium stearate
Cellulose, microcrystalline (E460)
Sodium laurilsulfate (E487)

Capsule shell:

Gelatin
Brilliant blue FCF (E133)
Erythrosine (E127)
Sunset yellow (E110)
Titanium dioxide (E171)

Printing ink:

Shellac (E904)
Titanium dioxide (E171)
Isopropyl alcohol
Ammonium hydroxide (E527)
Butyl alcohol
Propylene glycol
Simeticone

Pack sizes and marketing

High-density polyethylene (HDPE) bottles with a polypropylene child-resistant cap.

Pack-size of 84 (2 bottles of 42) hard capsules.

Marketing authorization holder

SIGA Technologies Netherlands B.V., Prinsenhil 29, Breda 4825 AX, The Netherlands

Marketing authorization dates and numbers

EU/1/21/1600/001

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.